Ausgabe 1/2009
Inhalt (31 Artikel)
Is red meat intake a risk factor for breast cancer among premenopausal women?
Valerie H. Taylor, Monali Misra, Som D. Mukherjee
Vitreo-retinal traction and anastrozole use
Alvin Eisner, Emily J. Thielman, Julie Falardeau, John T. Vetto
Genomic instability demonstrates similarity between DCIS and invasive carcinomas
Christopher M. Heaphy, Marco Bisoffi, Nancy E. Joste, Kathy B. Baumgartner, Richard N. Baumgartner, Jeffrey K. Griffith
When genomic and standard test results diverge: implications for breast cancer patients’ preference for chemotherapy
Noel T. Brewer, Alrick S. Edwards, Suzanne C. O’Neill, Janice P. Tzeng, Lisa A. Carey, Barbara K. Rimer
TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro
Rebecca L. H. Bigelow, Briana J. Williams, Jennifer L. Carroll, Lisa K. Daves, James A. Cardelli
Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo
Rui Wang, Xi Wang, Bin Li, Fang Lin, Ke Dong, Ping Gao, Hui-Zhong Zhang
BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer
Weiqiu Chen, Kaifeng Pan, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Youyong Lu, Weicheng You, Yuntao Xie
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow
Anthony Lucci, Savitri Krishnamurthy, Balraj Singh, Isabelle Bedrosian, Funda Meric-Bernstam, James Reuben, Kristine Broglio, Kailash Mosalpuria, Ashutosh Lodhi, Laura Vincent, Massimo Cristofanilli
Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trial
Louis Mauriac, Gilles Romieu, José Bines
Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant
Leilani Morales, Patrick Neven, Dirk Timmerman, Hans Wildiers, Maja L. Konstantinovic, Marie-Rose Christiaens, Peter N. Tan, Robert Paridaens
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
Aruna Mani, Julie Roda, Donn Young, Michael A. Caligiuri, Gini F. Fleming, Peter Kaufman, Adam Brufsky, Susan Ottman, William E. Carson III, Charles L. Shapiro
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
James Mansell, Ian J. Monypenny, Anthony I. Skene, Paul Abram, Robert Carpenter, Jennifer M. Gattuso, Christopher R. Wilson, Wilson J. Angerson, Julie C. Doughty
Comparing patients’ and clinicians’ assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)
Michaella J. Smith, P. Grantley Gill, Neil Wetzig, Tatiana Sourjina, Val Gebski, Owen Ung, Ian Campbell, James Kollias, Xanthi Coskinas, Avis Macphee, Leonie Young, R. John Simes, Martin R. Stockler
Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users
Sharon J. Wayne, Marian L. Neuhouser, Carol Koprowski, Cornelia M. Ulrich, Charles Wiggins, Frank Gilliland, Kathy B. Baumgartner, Richard N. Baumgartner, Anne McTiernan, Leslie Bernstein, Rachel Ballard-Barbash
Analysis of the effect of age on the prognosis of breast cancer
C. Cluze, M. Colonna, L. Remontet, F. Poncet, E. Sellier, A. Seigneurin, P. Delafosse, N. Bossard
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
Biyun Qian, Dionyssios Katsaros, Lingeng Lu, Mario Preti, Antonio Durando, Riccardo Arisio, Lina Mu, Herbert Yu
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
Ya-shuang Zhao, Sui Zhu, Xiang-wei Li, Fan Wang, Fu-lan Hu, Dan-dan Li, Wen-cui Zhang, Xia Li
Low penetrance breast cancer predisposition SNPs are site specific
Niall Mcinerney, Gabrielle Colleran, Andrew Rowan, Axel Walther, Ella Barclay, Sarah Spain, Angela M. Jones, Stephen Tuohy, Catherine Curran, Nicola Miller, Michael Kerin, Ian Tomlinson, Elinor Sawyer
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk
Pablo Serrano-Fernández, Tadeusz Dębniak, Bohdan Górski, Natalia Bogdanova, Thilo Dörk, Cezary Cybulski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Dominika Wokołorczyk, Steven A. Narod, Jan Lubiński
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry
Ellen T. Chang, Roger L. Milne, Kelly-Anne Phillips, Jane C. Figueiredo, Meera Sangaramoorthy, Theresa H. M. Keegan, Irene L. Andrulis, John L. Hopper, Pamela J. Goodwin, Frances P. O’Malley, Nayana Weerasooriya, Carmel Apicella, Melissa C. Southey, Michael L. Friedlander, Graham G. Giles, Alice S. Whittemore, Dee W. West, Esther M. John
Single frequency versus bioimpedance spectroscopy for the assessment of lymphedema
S. L. York, L. C. Ward, S. Czerniec, M. J. Lee, K. M. Refshauge, S. L. Kilbreath
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
Anita L. Bane, Dushanthi Pinnaduwage, Sarah Colby, Shelley B. Bull, Frances P. O’Malley, Irene L. Andrulis
Lobular involution: localized phenomenon or field effect?
Robert A. Vierkant, Lynn C. Hartmann, V. Shane Pankratz, Stephanie S. Anderson, Derek Radisky, Marlene H. Frost, Celine M. Vachon, Karthik Ghosh, Tammy J. Distad, Amy C. Degnim, Carol A. Reynolds
Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer
Maithili V. Rao, Michelle Shayne
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
William D. Foulkes, Matthew J. Grainge, Emad A. Rakha, Andrew R. Green, Ian O. Ellis
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
Marjorie Zauderer, Sujata Patil, Arti Hurria
Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series
Giuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, Enrico Orvieto, Eugenio Maiorano, Viviana Galimberti, Alberto Luini, Marco Colleoni, Aron Goldhirsch, Alan S. Coates
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu
Ana Peixoto, Catarina Santos, Patrícia Rocha, Pedro Pinto, Susana Bizarro, Manuel R. Teixeira
Sustained lower rates of breast cancer in the United States
Kathleen A. Cronin, Peter M. Ravdin, Brenda K. Edwards